| Validation of large white pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues B Brunet, C Doucet, N Venisse, T Hauet, W Hébrard, Y Papet, G Mauco, ... Forensic science international 161 (2-3), 169-174, 2006 | 128 | 2006 |
| In-source CID mass spectral libraries for the “general unknown” screening of drugs and toxicants P Marquet, N Venisse, E Lacassie, G Lachâtre Analusis 28 (10), 925-934, 2000 | 96 | 2000 |
| Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors A Barbot, N Venisse, F Rayeh, S Bouquet, B Debaene, O Mimoz Intensive care medicine 29, 1528-1534, 2003 | 93 | 2003 |
| A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry N Venisse, P Marquet, E Duchoslav, JL Dupuy, G Lachatre Journal of analytical toxicology 27 (1), 7-14, 2003 | 86 | 2003 |
| Preparation and stability of voriconazole eye drop solution A Dupuis, N Tournier, G Le Moal, N Venisse Antimicrobial agents and chemotherapy 53 (2), 798-799, 2009 | 80 | 2009 |
| Tissue Distribution of Indinavir Administered as Solid Lipid Nanocapsule Formulation in mdr1a (+/+) and mdr1a (−/−) CF-1 Mice M Pereira de Oliveira, E Garcion, N Venisse, JP Benoît, W Couet, ... Pharmaceutical research 22, 1898-1905, 2005 | 67 | 2005 |
| Mechanism-Based Pharmacokinetic-Pharmacodynamic Models of In Vitro Fungistatic and Fungicidal Effects against Candida albicans N Venisse, N Grégoire, M Marliat, W Couet Antimicrobial agents and chemotherapy 52 (3), 937-943, 2008 | 50 | 2008 |
| Urinary and blood concentrations of β2-agonists in trained subjects: comparison between routes of use A Pichon, N Venisse, E Krupka, MC Perault-Pochat, A Denjean International journal of sports medicine 27 (03), 187-192, 2006 | 48 | 2006 |
| Reliable quantification of bisphenol A and its chlorinated derivatives in human urine using UPLC–MS/MS method N Venisse, C Grignon, B Brunet, S Thévenot, A Bacle, V Migeot, A Dupuis Talanta 125, 284-292, 2014 | 45 | 2014 |
| Determination of bisphenol A in water and the medical devices used in hemodialysis treatment A Bacle, S Thevenot, C Grignon, M Belmouaz, M Bauwens, B Teychene, ... International journal of pharmaceutics 505 (1-2), 115-121, 2016 | 39 | 2016 |
| Development and validation of an LC–MS/MS method for the simultaneous determination of bisphenol A and its chlorinated derivatives in adipose tissue N Venisse, G Cambien, J Robin, S Rouillon, C Nadeau, T Charles, ... Talanta 204, 145-152, 2019 | 36 | 2019 |
| Bisphenol A, chlorinated derivatives of bisphenol A and occurrence of myocardial infarction in patients with type 2 diabetes: nested case-control studies in two European cohorts C Hu, B Schöttker, N Venisse, F Limousi, PJ Saulnier, M Albouy-Llaty, ... Environmental Science & Technology 53 (16), 9876-9883, 2019 | 34 | 2019 |
| Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered A Veinstein, N Venisse, J Badin, M Pinsard, R Robert, A Dupuis Antimicrobial agents and chemotherapy 57 (2), 977-982, 2013 | 34 | 2013 |
| Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection N Venisse, G Peytavin, S Bouchet, MC Gagnieu, R Garraffo, ... Antiviral Research 181, 104866, 2020 | 33 | 2020 |
| An overview of the literature on emerging pollutants: chlorinated derivatives of Bisphenol A (ClxBPA) N Plattard, A Dupuis, V Migeot, S Haddad, N Venisse Environment International 153, 106547, 2021 | 32 | 2021 |
| Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen Y Cazaubon, N Venisse, O Mimoz, P Maire, M Ducher, L Bourguignon, ... Journal of Antimicrobial Chemotherapy 72 (10), 2804-2812, 2017 | 32 | 2017 |
| Preparation and physicochemical stability of liquid oral dosage forms free of potentially harmful excipient designed for pediatric patients G Binson, K Beuzit, V Migeot, L Marco, B Troussier, N Venisse, A Dupuis Pharmaceutics 11 (4), 190, 2019 | 28 | 2019 |
| Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography E Cateau, N Tournier, A Dupuis, G Le Moal, N Venisse Journal of pharmaceutical and biomedical analysis 39 (3-4), 791-795, 2005 | 28 | 2005 |
| A simple and sensitive liquid chromatography–tandem mass spectrometry assay for the quantification of ertapenem in microdialysate S Lefeuvre, N Venisse, S Marchand, M Bachelet, W Couet Journal of Chromatography B 862 (1-2), 242-245, 2008 | 26 | 2008 |
| Ultrasensitive determination of bisphenol A and its chlorinated derivatives in urine using a high-throughput UPLC-MS/MS method C Grignon, N Venisse, S Rouillon, B Brunet, A Bacle, S Thevenot, ... Analytical and bioanalytical chemistry 408, 2255-2263, 2016 | 25 | 2016 |
